Clinical Trial
Published on 16 Jul 2025
Safety and immunogenicity of a recombinant double-mutant heat-labile toxin derived from enterotoxigenic Escherichia coli in healthy Bangladeshi adults delivered by three different routes
in Pathogenesis, Vaccines, and Immunity of Bacterial Infections
Frontiers in Bacteriology
doi 10.3389/fbrio.2025.1567791
- 2,513 views
- 2 citations
